NO20065328L - Indazol- og indolon-derivarter, og anvendelse av disse som farmasoytiske midler. - Google Patents

Indazol- og indolon-derivarter, og anvendelse av disse som farmasoytiske midler.

Info

Publication number
NO20065328L
NO20065328L NO20065328A NO20065328A NO20065328L NO 20065328 L NO20065328 L NO 20065328L NO 20065328 A NO20065328 A NO 20065328A NO 20065328 A NO20065328 A NO 20065328A NO 20065328 L NO20065328 L NO 20065328L
Authority
NO
Norway
Prior art keywords
disorders
sexual
disorder
lack
compounds
Prior art date
Application number
NO20065328A
Other languages
English (en)
Norwegian (no)
Inventor
Charlotte Moira Norfo Allerton
David Hepworth
Duncan Charles Miller
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411810A external-priority patent/GB0411810D0/en
Priority claimed from GB0415455A external-priority patent/GB0415455D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO20065328L publication Critical patent/NO20065328L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20065328A 2004-05-26 2006-11-20 Indazol- og indolon-derivarter, og anvendelse av disse som farmasoytiske midler. NO20065328L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0411810A GB0411810D0 (en) 2004-05-26 2004-05-26 New indazole and indolone derivatives and their use as pharmaceuticals
GB0415455A GB0415455D0 (en) 2004-07-09 2004-07-09 New indazole and indolone derivatives and their use as pharmaceuticals
PCT/IB2005/001513 WO2005116027A2 (en) 2004-05-26 2005-05-17 Indazole and indolone derivatives and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
NO20065328L true NO20065328L (no) 2006-12-18

Family

ID=35219654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065328A NO20065328L (no) 2004-05-26 2006-11-20 Indazol- og indolon-derivarter, og anvendelse av disse som farmasoytiske midler.

Country Status (25)

Country Link
EP (1) EP1753763B1 (ja)
JP (2) JP4093588B2 (ja)
AP (1) AP2006003823A0 (ja)
AR (1) AR049191A1 (ja)
AT (1) ATE404560T1 (ja)
AU (1) AU2005247696A1 (ja)
BR (1) BRPI0511533A (ja)
CA (1) CA2568050A1 (ja)
CR (1) CR8772A (ja)
DE (1) DE602005008954D1 (ja)
EA (1) EA200601985A1 (ja)
EC (1) ECSP067024A (ja)
ES (1) ES2308492T3 (ja)
GT (1) GT200500118A (ja)
IL (1) IL179365A0 (ja)
MA (1) MA28606B1 (ja)
MX (1) MXPA06013759A (ja)
NL (1) NL1029128C2 (ja)
NO (1) NO20065328L (ja)
PA (1) PA8635001A1 (ja)
PE (1) PE20060289A1 (ja)
SV (1) SV2005002128A (ja)
TW (1) TW200607500A (ja)
UY (1) UY28918A1 (ja)
WO (1) WO2005116027A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR078411A1 (es) 2009-05-07 2011-11-09 Lilly Co Eli Compuesto de vinil imidazolilo y composicion farmaceutica que lo comprende
US9259409B2 (en) * 2011-01-24 2016-02-16 Inceptum Research & Therapeutics, Inc. Compositions comprising a prostaglandin for treating neuropsychiatric conditions
CN107108556B (zh) * 2014-11-03 2020-09-29 艾欧米制药有限公司 药用化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023035A2 (en) * 1992-05-18 1993-11-25 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
WO1998035942A1 (en) * 1997-02-18 1998-08-20 American Home Products Corporation 4-aminoethoxyindazole derivatives
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
RS51442B (en) * 2002-12-10 2011-04-30 Pfizer Inc. MORPHOLINE DERIVATIVES USED AS DOPAMINE AGONISTS IN TREATMENT I.A. SEXUAL DYSFUNCTIONS

Also Published As

Publication number Publication date
CR8772A (es) 2006-12-13
AR049191A1 (es) 2006-07-05
BRPI0511533A (pt) 2008-01-02
TW200607500A (en) 2006-03-01
AU2005247696A1 (en) 2005-12-08
NL1029128C2 (nl) 2006-06-14
ES2308492T3 (es) 2008-12-01
PE20060289A1 (es) 2006-04-22
CA2568050A1 (en) 2005-12-08
EA200601985A1 (ru) 2007-04-27
JP4093588B2 (ja) 2008-06-04
UY28918A1 (es) 2005-12-30
ATE404560T1 (de) 2008-08-15
WO2005116027A3 (en) 2006-04-13
IL179365A0 (en) 2007-03-08
EP1753763B1 (en) 2008-08-13
MXPA06013759A (es) 2007-02-08
AP2006003823A0 (en) 2006-12-31
WO2005116027A2 (en) 2005-12-08
DE602005008954D1 (de) 2008-09-25
GT200500118A (es) 2006-01-10
EP1753763A2 (en) 2007-02-21
ECSP067024A (es) 2006-12-29
MA28606B1 (fr) 2007-05-02
JP2008500329A (ja) 2008-01-10
NL1029128A1 (nl) 2005-11-30
JP2008074874A (ja) 2008-04-03
SV2005002128A (es) 2005-12-13
PA8635001A1 (es) 2006-05-16

Similar Documents

Publication Publication Date Title
NO20065326L (no) Aminopyridin-derivater som selektive dopamin D3 agonister
GEP20217265B (en) Glp-1 receptor agonists and uses thereof
ATE301652T1 (de) Piperazinderivate als agonisten des melanocortin- rezeptors
ATE342057T1 (de) Melanocortinrezeptoragonisten
DE602006012322D1 (de) Als androgen-rezeptor-modulatoren verwendbare tetrahydrocarbazol-derivate
DE602006003432D1 (de) Latoren des androgenrezeptors
UA97794C2 (ru) Цитотоксические агенты, которые включают производные томаймицина, и их терапевтическое применение
MA32903B1 (fr) Inhibiteurs de proteine-kinases
GEP20146131B (en) Carbazole compounds and therapeutic uses thereof
MY150518A (en) Substituted gamma lactams as therapeutic agents
PE20081596A1 (es) Derivados fluorinados de deferiprona
EA201400423A1 (ru) Фармацевтические препараты и их применение при лечении половой дисфункции у женщин
NO20065328L (no) Indazol- og indolon-derivarter, og anvendelse av disse som farmasoytiske midler.
MX2008002065A (es) Derivados de pirazola como agentes terapeuticos.
MA33500B1 (fr) Dérivés de pyrazoles, leur préparation et leur application en thérapeutique
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
UA95780C2 (en) Xanthine derivatives as selective hm74a agonists
EA201290532A1 (ru) Бициклические тиазолы в качестве аллостерических модуляторов рецепторов mglur5
DOP2005000093A (es) Nuevos derivados de indazol e indolona y su uso como productos farmaceuticos
DOP2005000095A (es) Nuevos derivados de aminopiridina y su uso como farmacos
GB2423029A (en) Penis erection-enhancing device and methods of use thereof
MX2012014968A (es) Dosis fija de una combinacion farmaceutica de tadalafilo y dapoxetina.
TW200509891A (en) Selective serotonin reuptake inhibitors in the treatment of disease
RU2009108357A (ru) Способ терапии расстройств эрекции у мужчин